EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieRandomisierte kontrollierte StudieVideo/Audio

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B

Jinlin Hou, Wenhong Zhang, Qing Xie, Rui Hua, Hong Tang, Luis Enrique Morano Amado, Sheng-Shun Yang, Cheng-Yuan Peng, Wei-Wen Su, Wan-Long Chuang, Dong Joon Kim, Anchalee Avihingsanon und 25 weitere

New England Journal of Medicine · 05.12.2024 · 391 (22) · 2098-2109

DOI: 10.1056/nejmoa2405485 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 05.12.2024. Verfasst von Jinlin Hou und 36 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University (J.H., X.L.), and the State Key Laborat…. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B Surface Antigens, Hepatitis B, Chronic, Immunomodulating Agents. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: F. Hoffmann-La Roche, Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis B Surface AntigensHepatitis B, ChronicImmunomodulating AgentsInterferon-alphaRNA, Small InterferingAdultFemaleHumansMaleMiddle AgedDrug Therapy, CombinationHepatitis B virusNucleosidesPolyethylene GlycolsRecombinant ProteinsTreatment OutcomeOrganic Chemicals

Substanzen

Antiviral AgentsHepatitis B Surface AntigensImmunomodulating AgentsInterferon-alphaNucleosidesPolyethylene GlycolsRecombinant ProteinsRNA, Small Interferingpeginterferon alfa-2aRO7020531

Autor:innen und Institutionen

  • From the Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University (J.H., X.L.), and the State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases R…

ORCID-Profile: Jia-Horng Kao, Tarik Asselah

Förderung

  • F. Hoffmann-La Roche
  • Genentech

Zitieren

APA

Hou, J., Zhang, W., Xie, Q., Hua, R., Tang, H., Morano Amado, L. E., Yang, S. S., Peng, C. Y., Su, W. W., Chuang, W. L., Kim, D. J., Avihingsanon, A., Kao, J. H., Leerapun, A., Yuen, M. F., Asselah, T., Liang, X., Bo, Q., Canducci, F., …, & Piranga Study Group (2024). Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. New England Journal of Medicine, 391(22), 2098-2109. https://doi.org/10.1056/nejmoa2405485

Vancouver

Hou J, Zhang W, Xie Q, Hua R, Tang H, Morano Amado LE, et al. Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. New England Journal of Medicine. 2024;391(22):2098-2109. doi:10.1056/nejmoa2405485

BibTeX
@article{Hou2024,
  author = {Hou, Jinlin and Zhang, Wenhong and Xie, Qing and Hua, Rui and Tang, Hong and Morano Amado, Luis Enrique and Yang, Sheng-Shun and Peng, Cheng-Yuan and Su, Wei-Wen and Chuang, Wan-Long and Kim, Dong Joon and Avihingsanon, Anchalee and Kao, Jia-Horng and Leerapun, Apinya and Yuen, Man-Fung and Asselah, Tarik and Liang, Xieer and Bo, Qingyan and Canducci, Filippo and Catanese, Maria Teresa and Chen, Ethan and Cheng, Cong and Chughlay, Farouk and Das, Sudip and Glavini, Katerina and Guerreiro, Nelson and Huang, Yan and Kakrana, Priyanka and Kazma, Rémi and Patil, Avinash and Pavlovic, Vedran and Surujbally, Bernadette and Triyatni, Miriam and Upmanyu, Ruchi and Wat, Cynthia and Gane, Edward and Piranga Study Group, Piranga Study Group},
  title = {Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {22},
  pages = {2098--2109},
  doi = {10.1056/nejmoa2405485}
}
Kostenlos starten →